A breakthrough in AI breast cancer detection technology has been approved by the FDA. The tech company, "Clairity," is responsible for the first FDA-approved AI platform that helps predict a woman ...

"I have stage four lung cancer, which is not curable," Lin told his class. "I will likely die of this cancer or something related to this cancer. It may be one year, it may be two years ...

In a news release yesterday, the hospital said its launch of the technology, named PANCREASaver, late last year represents a major breakthrough in the early detection and treatment of pancreatic ...

Additional Breast Cancer Scans Can Triple Detection In Women With Dense Breasts By Dennis Thompson HealthDay ReporterTHURSDAY, May 22, 2025 (HealthDay News) — Louise Duffield, 60, was relieved ...

and less likely to have access to high-quality early cancer detection. While scientists know which cancers are fueling the growth of diagnoses in women, they still don’t totally understand why ...

Before they become invasive, at stages known as dysplasia and carcinoma in situ, early cancer cells alter the ... spectroscopy has the potential to detect epithelial precancerous lesions and ...

Four months after his diagnosis, he said, he had surgery to remove the cancer and his prostate and he hasn't had any issues since. With all cancers, early detection is key. And if it wasn't for ...

“With the main goal of catching disease earlier, and that is utilizing early cancer detection tests using genomics and using artificial intelligence to look at our populations to say who may be ...

Biologists from the University of the Philippines Diliman have developed a mathematical model that can detect lymphovascular invasion (LVI), an early indicator of metastasis, in breast cancer patients ...

Biden's disclosure of his diagnosis came around the time a book by journalists Jake Tapper and Alex Thompson published, titled, "Original Sin: President Biden's Decline, Its Cover-Up, and His ...

It is the first and only PROTAC ER degrader to be evaluated in a phase 3 clinical trial in breast cancer. PROTACs represent a novel class of therapeutic agents that harness the proteasome to ...